Lenalidomide 25mg

DRUG4 trials

Sponsors

Boston VA Research Institute, Inc., Ruijin Hospital, Samsung Medical Center, Seoul National University Hospital

Conditions

Amyloidosis CardiacDiffuse Large B Cell LymphomaMultiple MyelomaRelapsed and/or Refractory Non-Hodgkin T-cell Lymphoma

Phase 2

Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma

CompletedNCT01380106

Boston VA Research Institute, Inc.Multiple Myeloma

Start: 2010-08-31End: 2017-09-11Updated: 2021-01-25

Phase II of Lenalidomide After Salvage Therapy in R/R Non-Hodgkin T-cell Lymphoma

Samsung Medical CenterRelapsed and/or Refractory Non-Hodgkin T-cell Lymphoma

Start: 2018-11-16End: 2023-11-30Target: 79Updated: 2020-10-22

Phase 3

Frontline Lenalidomide for AL Amyloidosis Involving Myocardium

CompletedNCT04298372

Seoul National University HospitalAmyloidosis Cardiac

Start: 2019-02-20End: 2021-11-25Updated: 2024-04-17

Unknown Phase

Lenalidomide Based Immunotherapy in the Treatment of DLBCL

Ruijin HospitalDiffuse Large B Cell Lymphoma

Start: 2018-10-18End: 2020-09-15Target: 200Updated: 2019-07-08